Diagnosis and Management of Prenatal Hereditary Pyropoikilocytosis.
Hartzell C, Stover S, Gibson N, Olson T, Connelly J, Grace M, Andrews J.
Prenat Diagn. 2025 Jul 26. doi: 10.1002/pd.6867. Online ahead of print.
Hereditary pyropoikilocytosis resulting in artefactual thrombocytosis.
Molina-Arrebola MA, Morales-Pineda M, Bain BJ.
Br J Haematol. 2025 Jan;206(1):13-14. doi: 10.1111/bjh.19868. Epub 2024 Nov 6.
Hereditary Elliptocytosis with Pyropoikilocytosis.
Bayhan T, Ünal Ş, Gümrük F.
Turk J Haematol. 2016 Mar 5;33(1):86-7. doi: 10.4274/tjh.2015.0054. Epub 2015 Aug 6.
Persistent neonatal jaundice resulting from hereditary pyropoikilocytosis.
Sivaguru G, Simini G, Bain BJ.
Am J Hematol. 2022 Apr;97(4):506-507. doi: 10.1002/ajh.26358. Epub 2021 Sep 29.
Hereditary Elliptocytosis.
Jha SK, Vaqar S.
2024 Feb 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Homozygous SPTA1-associated hereditary pyropoikilocytosis presenting as hydrops fetalis.
Brancamp R, Hughes CE, Dar A, Polic A, Zuckerwise LC, Booth GS.
Transfusion. 2024 Jan;64(1):189-193. doi: 10.1111/trf.17617. Epub 2023 Nov 29.
Molecular insights into hereditary elliptocytosis and pyropoikilocytosis: NGS uncovers multiple potential candidate genes.
Shome DK, Das P, Akbar GA, Taha S, Radhi A, Al-Saad K, Helmy R.
Ann Hematol. 2023 Sep;102(9):2343-2351. doi: 10.1007/s00277-023-05337-9. Epub 2023 Jul 4.
Hereditary Pyropoikilocytosis-a Frequently Fatal Prenatal Blood Disorder.
Ebrahimi-Fakhari D, Rössig C, Groll AH.
Dtsch Arztebl Int. 2025 May 30;122(11):297. doi: 10.3238/arztebl.m2025.0062.
Hereditary Pyropoikilocytosis as a Modifier of Sickle Cell Disease Severity.
Lantz M, Dolatshahi L.
J Pediatr Hematol Oncol. 2025 Apr 1;47(3):128-130. doi: 10.1097/MPH.0000000000003012. Epub 2025 Mar 3.
Hereditary pyropoikilocytosis diagnosis in an infant: benefit of histograms and peripheral smear review.
Bobée V, Daliphard S, Lahary A.
Ann Biol Clin (Paris). 2020 Jun 1;78(3):343. doi: 10.1684/abc.2020.1552.
